SCH-58261 (Serbian Wikipedia)
Analysis of information sources in references of the Wikipedia article "SCH-58261" in Serbian language version.
refsWebsite
Global rank
Serbian rank
6th place
5th place
archive.org (Global: 6th place; Serbian: 5th place)
- Popoli P, Reggio R, Pèzzola A, Fuxe K, Ferré S (1998). „Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats”. Neuroscience Letters. 251 (3): 201—4. PMID 9726378. doi:10.1016/S0304-3940(98)00533-3.
- El Yacoubi M, Ledent C, Ménard JF, Parmentier M, Costentin J, Vaugeois JM (2000). „The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors”. British Journal of Pharmacology. 129 (7): 1465—73. PMC 1571962
. PMID 10742303. doi:10.1038/sj.bjp.0703170. - Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, Pèzzola A, Scarchilli L, Quarta D, Reggio R, Malchiodi-Albedi F, Falchi M, Massotti M (2002). „Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum”. Journal of Neuroscience. 22 (5): 1967—75. PMID 11880527.
- Canas PM, Porciúncula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA (2009). „Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway”. Journal of Neuroscience. 29 (47): 14741—51. PMID 19940169. doi:10.1523/JNEUROSCI.3728-09.2009.
doi.org (Global: 2nd place; Serbian: 4th place)
- Svenningsson P, Nomikos GG, Ongini E, Fredholm BB (1997). „Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens”. Neuroscience. 79 (3): 753—64. PMID 9219939. doi:10.1016/S0306-4522(97)00046-8.
- Popoli P, Reggio R, Pèzzola A, Fuxe K, Ferré S (1998). „Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats”. Neuroscience Letters. 251 (3): 201—4. PMID 9726378. doi:10.1016/S0304-3940(98)00533-3.
- El Yacoubi M, Ledent C, Ménard JF, Parmentier M, Costentin J, Vaugeois JM (2000). „The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors”. British Journal of Pharmacology. 129 (7): 1465—73. PMC 1571962 . PMID 10742303. doi:10.1038/sj.bjp.0703170.
- Kuzmin A, Johansson B, Gimenez L, Ogren SO, Fredholm BB (2006). „Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice”. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16 (2): 129—36. PMID 16054807. doi:10.1016/j.euroneuro.2005.07.001.
- Monopoli A, Lozza G, Forlani A, Mattavelli A, Ongini E (1998). „Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats”. Neuroreport. 9 (17): 3955—9. PMID 9875735. doi:10.1097/00001756-199812010-00034.
- Melani A, Gianfriddo M, Vannucchi MG, Cipriani S, Baraldi PG, Giovannini MG, Pedata F (2006). „The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia”. Brain Research. 1073-1074: 470—80. PMID 16443200. doi:10.1016/j.brainres.2005.12.010.
- Minghetti L, Greco A, Potenza RL, Pezzola A, Blum D, Bantubungi K, Popoli P (2007). „Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration”. Journal of Neuropathology and Experimental Neurology. 66 (5): 363—71. PMID 17483693. doi:10.1097/nen.0b013e3180517477.
- Canas PM, Porciúncula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA (2009). „Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway”. Journal of Neuroscience. 29 (47): 14741—51. PMID 19940169. doi:10.1523/JNEUROSCI.3728-09.2009.
- Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M (2006). „Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease”. Journal of the Neurological Sciences. 248 (1-2): 48—52. PMID 16780890. doi:10.1016/j.jns.2006.05.038.
nih.gov (Global: 4th place; Serbian: 8th place)
ncbi.nlm.nih.gov
- Zocchi C, Ongini E, Conti A, Monopoli A, Negretti A, Baraldi PG, Dionisotti S (1996). „The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist”. The Journal of Pharmacology and Experimental Therapeutics. 276 (2): 398—404. PMID 8632302.
- Svenningsson P, Nomikos GG, Ongini E, Fredholm BB (1997). „Antagonism of adenosine A2A receptors underlies the behavioural activating effect of caffeine and is associated with reduced expression of messenger RNA for NGFI-A and NGFI-B in caudate-putamen and nucleus accumbens”. Neuroscience. 79 (3): 753—64. PMID 9219939. doi:10.1016/S0306-4522(97)00046-8.
- Popoli P, Reggio R, Pèzzola A, Fuxe K, Ferré S (1998). „Adenosine A1 and A2A receptor antagonists stimulate motor activity: evidence for an increased effectiveness in aged rats”. Neuroscience Letters. 251 (3): 201—4. PMID 9726378. doi:10.1016/S0304-3940(98)00533-3.
- El Yacoubi M, Ledent C, Ménard JF, Parmentier M, Costentin J, Vaugeois JM (2000). „The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors”. British Journal of Pharmacology. 129 (7): 1465—73. PMC 1571962 . PMID 10742303. doi:10.1038/sj.bjp.0703170.
- Kuzmin A, Johansson B, Gimenez L, Ogren SO, Fredholm BB (2006). „Combination of adenosine A1 and A2A receptor blocking agents induces caffeine-like locomotor stimulation in mice”. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16 (2): 129—36. PMID 16054807. doi:10.1016/j.euroneuro.2005.07.001.
- El Yacoubi M, Costentin J, Vaugeois JM (2003). „Adenosine A2A receptors and depression”. Neurology. 61 (11 Suppl 6): S82—7. PMID 14663017.
- Monopoli A, Lozza G, Forlani A, Mattavelli A, Ongini E (1998). „Blockade of adenosine A2A receptors by SCH 58261 results in neuroprotective effects in cerebral ischaemia in rats”. Neuroreport. 9 (17): 3955—9. PMID 9875735. doi:10.1097/00001756-199812010-00034.
- Popoli P, Pintor A, Domenici MR, Frank C, Tebano MT, Pèzzola A, Scarchilli L, Quarta D, Reggio R, Malchiodi-Albedi F, Falchi M, Massotti M (2002). „Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum”. Journal of Neuroscience. 22 (5): 1967—75. PMID 11880527.
- Melani A, Gianfriddo M, Vannucchi MG, Cipriani S, Baraldi PG, Giovannini MG, Pedata F (2006). „The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia”. Brain Research. 1073-1074: 470—80. PMID 16443200. doi:10.1016/j.brainres.2005.12.010.
- Minghetti L, Greco A, Potenza RL, Pezzola A, Blum D, Bantubungi K, Popoli P (2007). „Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration”. Journal of Neuropathology and Experimental Neurology. 66 (5): 363—71. PMID 17483693. doi:10.1097/nen.0b013e3180517477.
- Canas PM, Porciúncula LO, Cunha GM, Silva CG, Machado NJ, Oliveira JM, Oliveira CR, Cunha RA (2009). „Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway”. Journal of Neuroscience. 29 (47): 14741—51. PMID 19940169. doi:10.1523/JNEUROSCI.3728-09.2009.
- Chen JF, Xu K, Petzer JP, Staal R, Xu YH, Beilstein M, Sonsalla PK, Castagnoli K, Castagnoli N, Schwarzschild MA (2001). „Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease”. Journal of Neuroscience. 21 (10): RC143. PMID 11319241.
- Simola N, Fenu S, Baraldi PG, Tabrizi MA, Morelli M (2006). „Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease”. Journal of the Neurological Sciences. 248 (1-2): 48—52. PMID 16780890. doi:10.1016/j.jns.2006.05.038.